Is herpes zoster (shingles) contagious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Herpes Zoster Contagious?

Yes, herpes zoster (shingles) is contagious, but significantly less so than chickenpox—approximately 20% as transmissible—and can only spread varicella-zoster virus (VZV) to susceptible individuals through direct contact with fluid from active vesicles, potentially causing chickenpox (not shingles) in those who have never had chickenpox or the varicella vaccine. 1

Understanding the Transmission Mechanism

Herpes zoster results from reactivation of VZV that remains dormant in sensory ganglia after primary varicella infection, not from new exposure to the virus. 2 The critical distinction is that a person with shingles cannot give another person shingles directly—they can only transmit VZV, which causes chickenpox in susceptible individuals who lack immunity. 1 Shingles itself occurs only as reactivation in someone who previously had chickenpox or received the vaccine. 1

How Transmission Occurs

  • Direct contact with vesicular fluid is the primary route of transmission, as vesicular fluid harbors high concentrations of infectious viral particles. 1
  • Airborne transmission is possible but rare, primarily documented in healthcare settings where susceptible persons with no direct contact with the index patient have acquired infection. 1
  • Transmission requires contact with uncrusted lesions only—once lesions become fully crusted, the fluid disappears and viral shedding essentially stops. 1

Timeline of Contagiousness

The contagious period begins 1-2 days before rash onset and continues until all lesions have dried and crusted, typically 4-7 days after rash onset. 1 For non-crusting lesions (macules and papules), contagiousness ends when no new lesions appear within a 24-hour period. 1

Special Considerations for Immunocompromised Patients

  • Immunocompromised patients experience markedly extended contagious phases, with new lesions continuing to appear for 7-14 days or longer compared to 4-6 days in healthy individuals. 1
  • These patients have slower lesion healing and prolonged viral shedding, extending the time required for lesions to become fully dried and crusted. 1
  • Without prompt antiviral therapy, the risk of disseminated varicella-zoster infection rises to 10-20% in immunocompromised individuals. 1

Who Is at Risk of Infection?

High-risk populations who should avoid contact with active shingles include:

  • Pregnant women (particularly concerning if exposure occurs 5 days before to 2 days after delivery, with newborns facing 17-30% risk of severe infection). 1
  • Premature infants and neonates. 1
  • Immunocompromised persons of all ages. 1
  • Anyone without history of chickenpox or varicella vaccination. 1

Notably, maternal herpes zoster during pregnancy does not cause congenital varicella syndrome, unlike maternal varicella infection. 1

Practical Prevention Measures

For Patients with Active Shingles

  • Cover all lesions completely to prevent transmission. 1
  • Wash hands frequently with soap and water. 1
  • Use separate towels and pillows from household members. 1
  • Avoid contact with high-risk individuals until all lesions are crusted. 1
  • Maintain at least 6 feet physical separation from other patients in healthcare settings. 1

Healthcare Worker Restrictions

  • Healthcare workers with localized herpes zoster who are immunocompetent should cover all lesions completely and be restricted from caring for high-risk patients until all lesions have dried and crusted. 1
  • Healthcare workers with disseminated zoster or immunocompromised status must be excluded from duty until all lesions have dried and crusted. 1
  • Standard precautions with complete lesion coverage are mandatory even after return to work in high-risk settings. 1

Infection Control Precautions by Clinical Scenario

Immunocompetent Patients with Localized Herpes Zoster

  • Standard and contact precautions are sufficient, with complete lesion coverage. 1
  • Airborne precautions are not required. 1
  • Continue precautions until all lesions are dried and crusted. 1

Disseminated Herpes Zoster (Any Immune Status)

  • Airborne and contact precautions are mandatory. 1
  • Requires negative air-flow rooms. 1
  • Continue precautions until all lesions are dry and crusted. 1

Immunocompromised Patients with Any Herpes Zoster

  • Airborne and contact precautions required until disseminated infection is ruled out. 1
  • Negative air-flow room required. 1
  • These patients experience prolonged viral shedding and slower healing. 1

Common Pitfalls to Avoid

  • Assuming antiviral therapy immediately makes the patient non-contagious—viral shedding continues until lesions are fully crusted, regardless of treatment. 1
  • Allowing healthcare workers with herpes zoster to care for high-risk patients before lesions are fully crusted. 1
  • Inadequate covering of lesions, which can lead to transmission even with localized disease. 1
  • Failing to recognize prolonged viral shedding in immunocompromised patients. 1
  • Delaying immunomodulator therapy restart—therapy can only be reintroduced after all vesicles have crusted over and fever has resolved. 1

Return to Work Guidelines

  • For crusting lesions: Complete work clearance when all lesions are fully crusted. 1
  • For non-crusting lesions: Complete work clearance when no new lesions appear within 24 hours. 1
  • Healthcare workers must be restricted from contact with immunocompromised patients, pregnant women, neonates, and patients in protective environments until all lesions crust. 1

References

Guideline

Herpes Zoster Contagiousness and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.